Search Results

With uncertainty rocking the venture capital market in the biotech and pharma industry, analysts from JLL give their thoughts on what the market looks like and where it may be heading.

New markets are emerging, and a new report from the market research team at JLL pinpoints some of these growing areas.

JLL published its JLL 2020 U.S. Life Sciences Outlook, which ranks and tracks the progress of life sciences markets, particularly in how they relate to real estate development.

Strategic Health Care Investors to Expand THREAD’s Innovative Technology Solution Enabling Virtual Visits for Hybrid and Decentralized Clinical Research [27-August-2019] CHICAGO and NEW YORK , Aug. 27, 2019 /PRNewswire/ -- Water Street Healthcare Partners and JLL Partners announced today that they have acquired THREAD, an innovative provider of technology that enabl

Cato Research, LLC announced today that it has formed a strategic partnership with healthcare investors, JLL Partners and Water Street Healthcare Partners, to continue its growth and expansion.

Water Street Healthcare Partners and JLL Partners announced that they have signed an agreement to acquire Triplefin.

JLL has been recognized by global biopharmaceutical company Bristol-Myers Squibb with a Service Delivery Excellence Award announced at the company’s annual Global Suppliers Conference.

Water Street Healthcare Partners and JLL Partners announced that they have recruited Mark Thierer to chairman and Jim Lang to CEO of their rapidly growing life sciences services platform.

Named as one of the nation’s best employers for health and well-being

U.S. biopharmaceutical research and development spending reached a record $179 billion in 2018 and is expected to grow by $34 billion by 2024, an indication that companies are investing now to improve their future pipelines, according to JLL’s eighth annual Life Sciences Outlook.